ArticleCancer discovery2021

BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition.

Marco H Hofmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.